Adobe's AI Momentum Meets Market Skepticism as Backlog Quality Remains Key Hurdle

What happened

Adobe reported strong Q3 FY2026 results with 13% YoY revenue growth and 15% non-GAAP EPS growth, driven by robust subscription revenue and AI adoption, as highlighted in a Seeking Alpha article arguing the stock is undervalued. However, the DeepValue master report notes that despite these headline numbers, the market remains fixated on whether freemium AI usage will translate into durable paid growth, given that RPO slipped slightly to $22.16 billion and cRPO stayed flat at 67%. Total Adobe ARR climbed to $27.50 billion, up from $27.10 billion in the prior quarter, while AI-first ARR exceeded $500 million in Q2 and grew more than 150% year over year in Q3, and GenStudio ARR surpassed $1 billion. The stock trades at $252.23, down 29.7% over the past year, with a P/E of 14.1 and EV/EBITDA of 9.9, and the report’s base case implies fair value near $295, suggesting potential upside if monetization continues to improve. The key near-term catalysts are the Q4 FY2026 revenue guide of $6.80–$6.85 billion and whether the next ARR disclosure shows another step-up, with the CEO transition to Anil Chakravarthy on December 1 adding execution risk.

Implication

The current price of $252.23 is below the report’s base case of $295, offering a potential 17% upside, but the bear scenario of $210 is not far off if AI monetization falters. Investors should focus on the next quarterly disclosure: a Total Adobe ARR above $27.9 billion and RPO re-acceleration above $22.3 billion would likely trigger a positive re-rating. Conversely, if RPO remains flat or declines, or if Adobe extends unlimited-generation promotions, the thesis weakens and the stock could retest the $235 attractive entry level or lower. The company’s strong cash flow ($2.52B in Q3) and aggressive buybacks ($26.78B remaining authorization) provide downside support, but they also mask slower organic growth unless AI monetization improves. Given the upcoming CEO change and the market’s current skepticism, investors may want to wait for confirmation from the next quarterly report before adding to positions, but the risk/reward appears skewed to the upside for patient holders.

Thesis delta

The thesis remains largely intact from the master report: Adobe is a potential buy at these levels because AI monetization is progressing faster than the market acknowledges. However, the new article's emphasis on a 'rare 40% repricing window' may overstate the certainty, as the report's own assessment flags RPO decline and promotional risks. The shift is modest: the article confirms strong Q3 metrics but does not alter the core need to see backlog re-acceleration and sustained ARR growth in the next quarter.